Primary orbital and adnexal rhabdomyosarcoma: a study of 54 Asian Indian patients.

Eye Sarcoma orbit rhabdomyosarcoma tumor

Journal

Orbit (Amsterdam, Netherlands)
ISSN: 1744-5108
Titre abrégé: Orbit
Pays: England
ID NLM: 8301221

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: aheadofprint

Résumé

To describe the clinical presentation, management, and outcomes of orbital and adnexal rhabdomyosarcoma (RMS) in an Asian-Indian cohort and analyze the factors predictive of outcomes. Retrospective interventional case series of 54 patients of histopathology-proven RMS. The mean age of presentation with RMS was 10 years (median, 7 years; range, <1-54 years). The most common tumor location was the superonasal quadrant ( Despite aggressive treatment modalities, the 5-year disease-specific survival rate was 77% in Asian-Indian cohort. Age > 18 years at presentation was associated with a poorer prognosis.

Identifiants

pubmed: 39470775
doi: 10.1080/01676830.2024.2419058
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Ayushi Agarwal (A)

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Vijitha S Vempuluru (VS)

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Faraz Ali Mohammad (FA)

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Mohammed Hasnat Ali (MH)

Center for Biostatistics and Epidemiology, L V Prasad Eye Institute, Hyderabad, India.

Vijay Anand Reddy Palkonda (VAR)

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Swathi Kaliki (S)

The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.

Classifications MeSH